Compare $HYPR vs $VANI | Chartloom

Compare

$HYPR vs $VANI

Hyperfine Inc · Vivani Medical Inc

HYPR

Hyperfine Inc

VANI

Vivani Medical Inc

Compare $HYPR vs $VANI

Comparing Hyperfine Inc and Vivani Medical Inc

HYPRHyperfine Inc

VANIVivani Medical Inc

HYPRHyperfine Inc

Market cap

$92M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.92x

Rev growth (TTM)

53.2%

YTD performance

-3.9%

52W performance

-55.5%

FCF yield

-29.8%

VANIVivani Medical Inc

Market cap

$108M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-1.6%

52W performance

-9.4%

FCF yield

-24.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HYPR

VANI

Detailed metrics comparison

HYPR

Hyperfine Inc

VANI

Vivani Medical Inc

Market Cap

HYPR$92M

VANI$108M

Enterprise Value

HYPR$62M

VANI$88M

Price

HYPR$0.93

VANI$1.25

P/E Ratio

HYPRN/A

VANIN/A

P/S Ratio

HYPR5.59x

VANI32.83x

EV/Sales

HYPR3.76x

VANI0.00x

EV/EBITDA

HYPR0.00x

VANI0.00x

P/B Ratio

HYPR2.58x

VANI5.85x

P/FCF Ratio

HYPRN/A

VANIN/A

EV/FCF

HYPR-2.26x

VANI-3.32x

PEG Ratio

HYPRN/A

VANIN/A

Forward P/E (NTM)

HYPRN/A

VANIN/A

Forward P/S (NTM)

HYPR3.92x

VANIN/A

Revenue (TTM)

HYPR$17M

VANI$0

Revenue Growth (YoY)

HYPR53.2%

VANIN/A

Forward Rev Growth

HYPR30.2%

VANI0.0%

Gross Margin (TTM)

HYPR51.4%

VANI36.4%

Operating Margin (TTM)

HYPR0.0%

VANI0.0%

EBITDA Margin (TTM)

HYPR-196.5%

VANI0.0%

Net Margin (TTM)

HYPR-210.8%

VANI0.0%

FCF Margin (TTM)

HYPR-166.5%

VANIN/A

Net Income (TTM)

HYPR$-35M

VANI$-26M

FCF (TTM)

HYPR$-28M

VANI$-27M

EPS (TTM)

HYPR-$0.35

VANI-$0.30

ROE (TTM)

HYPR-10030.0%

VANI-19105.0%

ROA (TTM)

HYPR-6334.0%

VANI-7091.0%

ROIC (TTM)

HYPR-8431.0%

VANI-19105.0%

Cash

HYPR$43M

VANI$20M

Debt

HYPR$13M

VANI$0

Net Cash/Debt

HYPR$30M

VANI$20M

Current Ratio (TTM)

HYPR6.15x

VANI3.25x

Quick Ratio (TTM)

HYPR5.25x

VANI3.09x

Debt/Equity (TTM)

HYPR0.36x

VANI0.00x

Debt/Assets (TTM)

HYPR0.0%

VANI0.0%

Interest Coverage (TTM)

HYPRN/A

VANIN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

VANI0.00x

Beta

HYPR1.51

VANI2.52

52W Performance

HYPR-55.5%

VANI-9.4%

YTD Performance

HYPR-3.9%

VANI-1.6%

% from 52W High

HYPR-58.1%

VANI-34.9%

% from 52W Low

HYPR23.5%

VANI35.5%

Asset Turnover (TTM)

HYPR0.30x

VANI0.12x

FCF Yield (TTM)

HYPR-29.8%

VANI-24.6%

Earnings Yield (TTM)

HYPR-37.7%

VANI-24.4%

Dividend Yield (TTM)

HYPRN/A

VANIN/A

Rule of 40

HYPR-113.3

VANI0.0

EV/GP/RG

HYPR0.17

VANIN/A

Ticker research

View HYPR research View VANI research

Metric	HYPR Hyperfine Inc	VANI Vivani Medical Inc
Market & Valuation
Market Cap	$92M	$108M
Enterprise Value	$62M	$88M
Price	$0.93	$1.25
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	32.83x
EV/Sales	3.76x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	5.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-3.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	N/A
Revenue & Growth
Revenue (TTM)	$17M	$0
Revenue Growth (YoY)	53.2%	N/A
Forward Rev Growth	30.2%	0.0%
Profitability
Gross Margin (TTM)	51.4%	36.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	0.0%
Net Margin (TTM)	-210.8%	0.0%
FCF Margin (TTM)	-166.5%	N/A
Net Income (TTM)	$-35M	$-26M
FCF (TTM)	$-28M	$-27M
EPS (TTM)	-$0.35	-$0.30
ROE (TTM)	-10030.0%	-19105.0%
ROA (TTM)	-6334.0%	-7091.0%
ROIC (TTM)	-8431.0%	-19105.0%
Financial Health
Cash	$43M	$20M
Debt	$13M	$0
Net Cash/Debt	$30M	$20M
Current Ratio (TTM)	6.15x	3.25x
Quick Ratio (TTM)	5.25x	3.09x
Debt/Equity (TTM)	0.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	2.52
52W Performance	-55.5%	-9.4%
YTD Performance	-3.9%	-1.6%
% from 52W High	-58.1%	-34.9%
% from 52W Low	23.5%	35.5%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.12x
FCF Yield (TTM)	-29.8%	-24.6%
Earnings Yield (TTM)	-37.7%	-24.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	0.0
EV/GP/RG	0.17	N/A
Ticker research	View HYPR research	View VANI research

Valuation

P/S Ratio

HYPR

5.59x

VANI

32.83x

EV/FCF

VANI

-3.32x

HYPR

-2.26x

Growth & revenue

Revenue Growth TTM

HYPR

53.2%

Forward Revenue Growth

HYPR

30.2%

VANI

0.0%

Profitability & performance

Gross Margin

HYPR

51.4%

VANI

36.4%

ROE

HYPR

-10030.0%

VANI

-19105.0%

FCF Yield %

VANI

-24.6%

HYPR

-29.8%

52-Week Performance

VANI

-9.4%

HYPR

-55.5%

Detailed metrics comparison

HYPR

Hyperfine Inc

VANI

Vivani Medical Inc

Market Cap

HYPR$92M

VANI$108M

Enterprise Value

HYPR$62M

VANI$88M

Price

HYPR$0.93

VANI$1.25

P/E Ratio

HYPRN/A

VANIN/A

P/S Ratio

HYPR5.59x

VANI32.83x

EV/Sales

HYPR3.76x

VANI0.00x

EV/EBITDA

HYPR0.00x

VANI0.00x

P/B Ratio

HYPR2.58x

VANI5.85x

P/FCF Ratio

HYPRN/A

VANIN/A

EV/FCF

HYPR-2.26x

VANI-3.32x

PEG Ratio

HYPRN/A

VANIN/A

Forward P/E (NTM)

HYPRN/A

VANIN/A

Forward P/S (NTM)

HYPR3.92x

VANIN/A

Revenue (TTM)

HYPR$17M

VANI$0

Revenue Growth (YoY)

HYPR53.2%

VANIN/A

Forward Rev Growth

HYPR30.2%

VANI0.0%

Gross Margin (TTM)

HYPR51.4%

VANI36.4%

Operating Margin (TTM)

HYPR0.0%

VANI0.0%

EBITDA Margin (TTM)

HYPR-196.5%

VANI0.0%

Net Margin (TTM)

HYPR-210.8%

VANI0.0%

FCF Margin (TTM)

HYPR-166.5%

VANIN/A

Net Income (TTM)

HYPR$-35M

VANI$-26M

FCF (TTM)

HYPR$-28M

VANI$-27M

EPS (TTM)

HYPR-$0.35

VANI-$0.30

ROE (TTM)

HYPR-10030.0%

VANI-19105.0%

ROA (TTM)

HYPR-6334.0%

VANI-7091.0%

ROIC (TTM)

HYPR-8431.0%

VANI-19105.0%

Cash

HYPR$43M

VANI$20M

Debt

HYPR$13M

VANI$0

Net Cash/Debt

HYPR$30M

VANI$20M

Current Ratio (TTM)

HYPR6.15x

VANI3.25x

Quick Ratio (TTM)

HYPR5.25x

VANI3.09x

Debt/Equity (TTM)

HYPR0.36x

VANI0.00x

Debt/Assets (TTM)

HYPR0.0%

VANI0.0%

Interest Coverage (TTM)

HYPRN/A

VANIN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

VANI0.00x

Beta

HYPR1.51

VANI2.52

52W Performance

HYPR-55.5%

VANI-9.4%

YTD Performance

HYPR-3.9%

VANI-1.6%

% from 52W High

HYPR-58.1%

VANI-34.9%

% from 52W Low

HYPR23.5%

VANI35.5%

Asset Turnover (TTM)

HYPR0.30x

VANI0.12x

FCF Yield (TTM)

HYPR-29.8%

VANI-24.6%

Earnings Yield (TTM)

HYPR-37.7%

VANI-24.4%

Dividend Yield (TTM)

HYPRN/A

VANIN/A

Rule of 40

HYPR-113.3

VANI0.0

EV/GP/RG

HYPR0.17

VANIN/A

Ticker research

View HYPR research View VANI research

Metric	HYPR Hyperfine Inc	VANI Vivani Medical Inc
Market & Valuation
Market Cap	$92M	$108M
Enterprise Value	$62M	$88M
Price	$0.93	$1.25
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	32.83x
EV/Sales	3.76x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	5.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-3.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	N/A
Revenue & Growth
Revenue (TTM)	$17M	$0
Revenue Growth (YoY)	53.2%	N/A
Forward Rev Growth	30.2%	0.0%
Profitability
Gross Margin (TTM)	51.4%	36.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	0.0%
Net Margin (TTM)	-210.8%	0.0%
FCF Margin (TTM)	-166.5%	N/A
Net Income (TTM)	$-35M	$-26M
FCF (TTM)	$-28M	$-27M
EPS (TTM)	-$0.35	-$0.30
ROE (TTM)	-10030.0%	-19105.0%
ROA (TTM)	-6334.0%	-7091.0%
ROIC (TTM)	-8431.0%	-19105.0%
Financial Health
Cash	$43M	$20M
Debt	$13M	$0
Net Cash/Debt	$30M	$20M
Current Ratio (TTM)	6.15x	3.25x
Quick Ratio (TTM)	5.25x	3.09x
Debt/Equity (TTM)	0.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	2.52
52W Performance	-55.5%	-9.4%
YTD Performance	-3.9%	-1.6%
% from 52W High	-58.1%	-34.9%
% from 52W Low	23.5%	35.5%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.12x
FCF Yield (TTM)	-29.8%	-24.6%
Earnings Yield (TTM)	-37.7%	-24.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	0.0
EV/GP/RG	0.17	N/A
Ticker research	View HYPR research	View VANI research